Medical Condition News

RSS

QR Pharma awarded patent covering use of Posiphen and analogs in treatment of DS

QR Pharma, Inc., a developer of novel drugs to treat Alzheimer’s disease (AD), announced today that it was issued U.S. Patent No. 7,625,942, a "Method of Treating Down Syndrome" by the U.S. Patent and Trademark Office. The '942 patent covers use of Posiphen and analogs to treat cognitive impairments associated with Down Syndrome (DS). This patent valuably expands upon the original Posiphen and analog patent that claims composition of matter and use of compounds to lower amyloid-β precursor protein (APP) and thereby treat dementia and Alzheimer’s disease (AD).

24 Feb 2010

Diabetic Neuropathy: Drug having disease-modifying potential will earn 40% patient share in the U.S

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of diabetic neuropathy, a drug that has disease-modifying potential would earn 40 percent patient share in the U.S., according to surveyed U.S. neurologists. Similarly, in Europe, such a drug would earn a comparable patient share of 43 percent, according to surveyed European neurologists.

24 Feb 2010

Over-produced PKC-iota oncogene linked to poor pancreatic cancer patient survival

Researchers at the Mayo Clinic campus in Florida have found that PKC-iota (PKC), an oncogene important in colon and lung cancers, is over-produced in pancreatic cancer and is linked to poor patient survival. They also found that genetically inhibiting PKC in laboratory animals led to a significant decrease in pancreatic tumor growth and spread.

24 Feb 2010

AutoGenomics launches expanded test panel to detect 17 B-RAF mutations

AutoGenomics, a leader in providing automated, molecular testing solutions announced today that it has launched an expanded test panel to detect 17 B-RAF mutations for research use to enhance the understanding of B-RAF mutations.

24 Feb 2010

Different rates of post-traumatic stress disorder in different countries: Study

A study published in the current issue of Psychotherapy and Psychosomatics provides new insights in the different rates of post-traumatic stress disorder that are found in studies performed in different countries.

24 Feb 2010

Comparison study of two treatment strategies for severe sepsis reveals similar short-term survival rates

A comparison of two strategies for treating severe sepsis or septic shock finds that using lactate levels measured in blood samples showed a similar short-term survival rate compared to a treatment regimen using central venous oxygen saturation measured using a specialized catheter, according to a study in the February 24 issue of JAMA.

24 Feb 2010

Guardian offers six questions to help employees and their families avoid critical illness

If you want to protect your finances from the costs of heart disease, and keep your heart healthy, the experts at The Guardian Life Insurance Company of America, a leading provider of employee benefits, have compiled important questions that you should ask yourself before American Heart Month ends.

24 Feb 2010

Hospitalization may be a marker for cognitive decline or dementia in older patients, says study

Older patients hospitalized for acute care or a critical illness are more likely to experience cognitive decline compared to older adults who are not hospitalized, according to a study in the February 24 issue of JAMA.

24 Feb 2010

BioMedix Vascular Solutions, Howard University Hospital partner to help uninsured PAD patients

BioMedix Vascular Solutions, Inc. announced today that the company has partnered with Howard University Hospital, Department of Surgery to participate in a Community Health Project and Demonstration focused on diagnosing and treating the potentially life-threatening condition called Peripheral Arterial Disease (PAD).

24 Feb 2010

Special issue of NeuroRehabilitation journal devoted to HI-BI published

IOS Press announces publication of a special issue of NeuroRehabilitation: An International Journal devoted specifically to hypoxic-ischemic brain injury (HI-BI), a significant disruption of brain function due to a deficient supply of oxygen to the brain.

24 Feb 2010

Anxiety in German psychosomatic units: Long term extensive experience of treatment

A study published in the current issue of Psychotherapy and Psychosomatics reports on a long term extensive experience of treatment of psychosomatic symptoms related to anxiety in German psychosomatic units.

24 Feb 2010

ES cells-functions: Condensins promote mitotic progression and maintain interphase chromatin compaction

Regulatory proteins common to all eukaryotic cells can have additional, unique functions in embryonic stem (ES) cells, according to a study in the February 22 issue of the Journal of Cell Biology (www.jcb.org). If cancer progenitor cells-which function similarly to stem cells-are shown to rely on these regulatory proteins in the same way, it may be possible to target them therapeutically without harming healthy neighboring cells.

24 Feb 2010

Emerging oral atypical antipsychotics to compete in increasingly crowded schizophrenia drug market

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the world's major pharmaceutical markets, emerging oral atypical antipsychotics will compete against each other and against established drugs for the same niche patient population in the treatment of schizophrenia.

24 Feb 2010

Take 2 To Save 2 campaign: To send life-changing health messages to those who may be at risk for stroke

The American Stroke Association, a division of the American Heart Association, today launched a campaign that provides people an array of life-changing health messages to send to those who may be at risk for stroke.

24 Feb 2010

Joint science advisory issues messages for diabetics at risk for heart disease and stroke

The data are inconclusive on heart risks from a class of blood sugar-lowering drugs called thiazolidinediones (TZDs) such as pioglitazone (Actos) or rosiglitazone (Avandia), but the medications should be used with close monitoring from healthcare providers according to a joint science advisory from the American College of Cardiology and the American Heart Association.

24 Feb 2010

Religious belief can reduce depression symptoms

Research suggests that religious belief can help protect against symptoms of depression, but a study at Rush University Medical Center goes one step further.

24 Feb 2010

Arsenic exposure may increase cancer risk, says study

Researchers have found a new oncogenic signaling pathway by which the environmental toxin arsenic may lead to adverse health effects, including bladder cancer. These study results are published in Cancer Research, a journal of the American Association for Cancer Research.

24 Feb 2010

Research may lead to new therapeutic treatments for Huntington's disease

Huntington's disease (HD) is a cruel, hereditary condition that leads to severe physical and mental deterioration, psychiatric problems and eventually, death. Currently, there are no treatments to slow down or stop it. HD sufferers are born with the disease although they do not show symptoms until late in life.

24 Feb 2010

Gene expression in prostate cancer cell more complex than ever imagined

Scientists from Sydney's Garvan Institute of Medical Research have published a paper, online today in Nature Cell Biology, describing gene expression in a prostate cancer cell: more sweeping, more targeted and more complex than we could ever have imagined, even five years ago.

24 Feb 2010

Colonoscopies performed by non-gastroenterologists may increase risk of developing subsequent CRC

Following a negative complete colonoscopy, those who had their colonoscopies at a hospital and had their procedures performed by a non-gastroenterologist may be at a significantly increased risk of developing subsequent colorectal cancer (CRC), according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute.

24 Feb 2010

Medical Condition News

QR Pharma awarded patent covering use of Posiphen and analogs in treatment of DS

Diabetic Neuropathy: Drug having disease-modifying potential will earn 40% patient share in the U.S

Over-produced PKC-iota oncogene linked to poor pancreatic cancer patient survival

AutoGenomics launches expanded test panel to detect 17 B-RAF mutations

Different rates of post-traumatic stress disorder in different countries: Study

Comparison study of two treatment strategies for severe sepsis reveals similar short-term survival rates

Guardian offers six questions to help employees and their families avoid critical illness

Hospitalization may be a marker for cognitive decline or dementia in older patients, says study

BioMedix Vascular Solutions, Howard University Hospital partner to help uninsured PAD patients

Special issue of NeuroRehabilitation journal devoted to HI-BI published

Anxiety in German psychosomatic units: Long term extensive experience of treatment

ES cells-functions: Condensins promote mitotic progression and maintain interphase chromatin compaction

Emerging oral atypical antipsychotics to compete in increasingly crowded schizophrenia drug market

Take 2 To Save 2 campaign: To send life-changing health messages to those who may be at risk for stroke

Joint science advisory issues messages for diabetics at risk for heart disease and stroke

Religious belief can reduce depression symptoms

Arsenic exposure may increase cancer risk, says study

Research may lead to new therapeutic treatments for Huntington's disease

Gene expression in prostate cancer cell more complex than ever imagined

Colonoscopies performed by non-gastroenterologists may increase risk of developing subsequent CRC

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News